BVBA Dr. Everhard Vandervliet
The computed 12-month bankruptcy probability of BVBA Dr. Everhard Vandervliet is 0.1% (very low). The 2024 annual accounts show equity of €523k and a net result of €25k. Equity remains stable across the filed fiscal years (±0.3% per year). Its solvency ranks better than 48% of 382 sector peers (fiscal year 2024). The company has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €523k |
| Net result | €25k |
| Staff (FTE) | 2.8 |
| Better than sector | 48% |
Strong profile, led by stability.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 47.9% | 50.3% | |
| Net result | €25k | €72k | |
| Equity | €523k | €127k | |
| Gross operating margin | €377k | €179k | |
| Staff costs | €112k | €134k |
| Fiscal year | 2024 |
|---|---|
| Deposit | verkort |
| Revenue | - |
| EBITDA | €154k |
| Net profit | €25k |
| Cash flow | €78k |
| Staff costs | €112k |
| Income taxes | €17k |
| Dividends | €3k |
| Total assets | €1.09M |
| Equity | €523k |
| Debt | €569k |
| of which ≤ 1y | €178k |
| of which > 1y | €391k |
| Working capital | €275k |
| Employees (FTE) | 2.8 |
| 2024 | |
|---|---|
| Current ratio | 2.54 |
| Quick ratio | 2.54 |
| Working capital ratio | 25.2% |
| Solvency | 47.9% |
| Debt / equity | 1.09 |
| Long-term debt ratio | 0.75 |
| Interest coverage | 1.90 |
| Gross margin | - |
| Net margin | - |
| ROA | 2.3% |
| ROE | 4.8% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €1.09M |
| Fixed assets | 21/28 | €638k |
| Tangible fixed assets | 22/27 | €638k |
| Current assets | 29/58 | €454k |
| Amounts receivable within one year | 40/41 | €338k |
| Investments | 50/53 | €0 |
| Cash & bank | 54/58 | €115k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.09M |
| Equity | 10/15 | €523k |
| Contributions / capital | 10/11 | €13k |
| Reserves | 13 | €510k |
| Accumulated profits (losses) | 14 | €0 |
| Amounts payable | 17/49 | €569k |
| Amounts payable after one year | 17 | €391k |
| Amounts payable within one year | 42/48 | €178k |
| Trade debts payable within one year | 44 | €65k |
| Income statement | ||
| Gross operating margin | 9900 | €377k |
| Operating result | 9901 | €101k |
| Financial income | 75 | €22k |
| Financial charges | 65 | €81k |
| Result before taxes | 9903 | €42k |
| Income taxes | 67/77 | €17k |
| Net result for the period | 9904 | €25k |
| Result to be appropriated | 9905 | €25k |
| NACE primary | Human health(86220) |
| Legal form | Private limited company (pre-2019)(015) |
| Incorporation | 14-04-2011 |
| Status | Active |
| Postal code | 2600 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11003A0229/00D004 | Flanders | 1,317 m² | 1 · 323 m² | - |
| 11453I0170/00Z002 | Flanders | 587 m² | 1 · 137 m² | 11.1 m · 1 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | BVBA Dr. Everhard Vandervliet |
| AbbreviationNL | BVBA EVARA |